Brief: Argenx Q2 Net Income USD 29.066 Million
25/07/2024 06:00
Jul 25 (Reuters) - Argenx Q2 EPS USD 0.45. * Q2 operating expenses USD -534.889 million * Q2 total operating income USD 489.428 million * Q2 basic EPS USD 0.49
Recent news on argenx SE
See all newsArgenx falls after Vyvgart trial update on myositis drug, brokers remain positive
Brief: ArgenX Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit In Myositis And Sjogren’S Disease
Brief: argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
Brief: Argenx Q1 Total Operating Income USD 1.313 Bln
Netherlands' Argenx Q1 net sales rise 63%, profit more than doubles